We are live on ! Find out more
EA

Emerald Advisers Portfolio holdings

AUM $3.16B
1-Year Est. Return 109.58%
This Fund
S&P 500
This Quarter Est. Return
+13.92%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$2.07B
AUM Growth
+$131M
Cap. Flow
-$8.41M
Cap. Flow %
-0.41%
Top 10 Hldgs %
17.49%
Holding
270
New
21
Increased
72
Reduced
124
Closed
24

Top Buys

Rank Stock Value
1
INSM icon
Insmed
INSM
+$19.2M
2
CHX
ChampionX
CHX
+$16.3M
3
MRCY icon
Mercury Systems
MRCY
+$15.2M
4
AVAV icon
AeroVironment
AVAV
+$15M
5
AQUA
Evoqua Water Technologies Corp. Common Stock
AQUA
+$11.6M

Top Sells

Rank Stock Value
1
ITGR icon
Integer Holdings
ITGR
+$17.9M
2
TNDM icon
Tandem Diabetes Care
TNDM
+$14.3M
3
PCRX icon
Pacira BioSciences
PCRX
+$13.1M
4
HRT
HireRight Holdings Corporation
HRT
+$12.9M
5
IMGO
Imago BioSciences, Inc. Common stock
IMGO
+$12.8M

Sector Composition

Rank Sector Weight
1 Healthcare 30.79%
2 Industrials 15.85%
3 Consumer Discretionary 14.25%
4 Technology 13.06%
5 Financials 7.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TNET icon
26
TriNet
TNET
$2.74B
$25.9M 1.25%
381,453
-7,541
-2% -$520K
RETA
27
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$25.8M 1.25%
679,772
+141,520
+26% +$4.87M
CRS icon
28
Carpenter Technology
CRS
$27.7B
$25.8M 1.24%
697,323
+71,455
+11% +$2.72M
CELH icon
29
Celsius Holdings
CELH
$7.41B
$24.4M 1.18%
702,264
+64,833
+10% +$2.11M
PLMR icon
30
Palomar
PLMR
$3.59B
$24.2M 1.17%
535,334
+35,846
+7% +$2.44M
ATRC icon
31
AtriCure
ATRC
$1.77B
$22.9M 1.11%
517,117
+88,486
+21% +$3.7M
VRNS icon
32
Varonis Systems
VRNS
$5.46B
$22.8M 1.1%
954,210
-12,102
-1% -$277K
FWRD icon
33
Forward Air
FWRD
$435M
$22.2M 1.07%
211,233
+435
+0.2% +$45.6K
GTLS
34
DELISTED
Chart Industries
GTLS
$22M 1.07%
191,306
-76,048
-28% -$12.2M
MTDR icon
35
Matador Resources
MTDR
$6.68B
$21.7M 1.05%
379,685
-1,192
-0.3% -$75.2K
LNTH icon
36
Lantheus
LNTH
$7B
$21.7M 1.05%
426,039
+53,331
+14% +$3.29M
AHCO icon
37
AdaptHealth
AHCO
$1.49B
$21.7M 1.05%
1,127,131
+162,885
+17% +$3.44M
CYTK icon
38
Cytokinetics
CYTK
$10.9B
$21.6M 1.05%
472,310
+131,700
+39% +$5.67M
JACK icon
39
Jack in the Box
JACK
$286M
$21.3M 1.03%
312,615
+25,528
+9% +$1.96M
ONT
40
Onterris Inc
ONT
$756M
$21.2M 1.02%
477,705
+1,156
+0.2% +$48.9K
ACAD icon
41
Acadia Pharmaceuticals
ACAD
$4.38B
$21M 1.02%
1,322,146
-7,480
-0.6% -$117K
INSM icon
42
Insmed
INSM
$23.5B
$19.9M 0.96%
+994,913
New +$19.2M
KRTX
43
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$19.8M 0.96%
100,930
-18,898
-16% -$4.05M
MNKD icon
44
MannKind Corp
MNKD
$1.25B
$19.6M 0.95%
3,714,768
-50,516
-1% -$207K
KTOS icon
45
Kratos Defense & Security Solutions
KTOS
$8.63B
$19.5M 0.94%
1,892,592
-26,942
-1% -$268K
NEO icon
46
NeoGenomics
NEO
$1.9B
$19.4M 0.94%
2,101,567
-38,012
-2% -$354K
PRVA icon
47
Privia Health
PRVA
$3.39B
$19M 0.92%
836,069
+389,615
+87% +$10.8M
COLL icon
48
Collegium Pharmaceutical
COLL
$1.17B
$18.9M 0.91%
813,689
-3,460
-0.4% -$69.8K
ANIP icon
49
ANI Pharmaceuticals
ANIP
$1.8B
$17.8M 0.86%
443,236
-13,512
-3% -$508K
HRI icon
50
Herc Holdings
HRI
$4.99B
$17.8M 0.86%
135,125
+3,275
+2% +$402K
1
2
3 4 5

Similar funds

AWE
Avidian Wealth Enterprises Houston, Texas $3.16B AUM 20.31% 1-Year Est. Return
FTUS
Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return
BFA
Bragg Financial Advisors Charlotte, North Carolina $3.16B AUM 26% 1-Year Est. Return
BP
BNP Paribas Paris, France $3.15B AUM 22.54% 1-Year Est. Return
CVA
Ceredex Value Advisors Orlando, Florida $3.18B AUM 35.23% 1-Year Est. Return
DWP
Daymark Wealth Partners Cincinnati, Ohio $3.18B AUM 23.46% 1-Year Est. Return
GKWIM
Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.14B AUM 22.62% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Emerald Advisers's Q4 2022 Portfolio in Review

As of Q4 2022, Emerald Advisers held 270 positions worth $2.07B, up 6.8% from $1.94B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Emerald Advisers's Q4 2022 filing shows 21 new, 72 increased, 124 reduced and 24 closed positions. Its largest new stake was Insmed: 994,913 shares worth $19.9M. The largest sale was Integer Holdings, an estimated $17.9M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 31% a quarter earlier, followed by Industrials and Consumer Discretionary.

  • Emerald Advisers's largest Q4 2022 buy was Insmed: 994,913 shares worth $19.9M.
  • Emerald Advisers added most to Evoqua Water Technologies Corp. Common Stock in Q4 2022, an estimated $11.6M increase.
  • Emerald Advisers's biggest Q4 2022 reduction was Integer Holdings, cutting an estimated $17.9M.
  • Emerald Advisers fully exited Tandem Diabetes Care in Q4 2022, selling an estimated $14.3M.
  • Emerald Advisers's ten largest holdings make up 17% of its $2.07B portfolio in Q4 2022.
  • Emerald Advisers opened 21 new positions and closed 24 in Q4 2022.
  • Emerald Advisers's portfolio value rose 6.8% quarter-over-quarter to $2.07B.

Based on Emerald Advisers's 13F filing for Q4 2022, filed 3 Feb 2023.